Chinese medicinal decoction for treatment of ankylosing spondylitis

Abstract

The invention discloses a Chinese medicinal decoction for treatment of ankylosing spondylitis. The Chinese medicinal decoction is prepared from the following Chinese herbal medicines by weight: 8 parts of achyranthes bidentata, 9 parts of Dalbergia odorifera, 10 parts of Pegia nitida, 11 parts of cassia twig, 11 parts of ephedra, 4 parts of dried ginger, 8 parts of Taxillus sutchuenensis, 7 parts of Radix Stephaniae Tetrandrae, 6 parts of Japanese Honeysuckle Stem, 12 parts of Arundina graminifolia, 9 parts of Alisma plantago-aquatica, 8 parts of licorice, 10 parts of Premna microphylla, 6 parts of Morus nigra L., 5 parts of eucommia, 6 parts of Folium Alstoniae Scholaris, 12 parts of Tamarix chinensis seed, 5 parts of leaf of chinese ilex, 5 parts of root of Laportea bulbifera, 6 parts of willow twig, 5 parts of seed of allium fistulosum, 4 parts of cornus officinalis, 5 parts of Angiopteris hokouensis, and 4 parts of Pittosporum glabratum root. Clinical experiments prove that through reasonable compatibility of the traditional Chinese medicines, the Chinese medicinal decoction provided by the invention is conducive to treating ankylosing spondylitis, also can effectively prevent relapse, and reaches the good efficacy of overall regulation and long-term effect.

Description

technical field [0001] The invention relates to a traditional Chinese medicine decoction, in particular to a traditional Chinese medicine decoction for treating ankylosing spondylitis. Background technique [0002] Ankylosing spondylitis is one of the world's medical problems, mostly in young and middle-aged men. The disease mainly involves the skeletal joints and spinal attachment points, and can also affect the large joints of the limbs. The early clinical manifestations are not typical, and symptoms such as low-grade fever, fatigue, and weight loss may occur, resulting in many patients being misdiagnosed or missing the opportunity for treatment. In the middle and late stages, it can lead to The spine is stiff and rigid, and the joints are twisted and deformed, causing the patient to lose basic physical functions, causing severe pain to the patient, and bringing a heavy burden to the family and even the society. Western medicine is still not completely clear about its pat...

AI Technical Summary

Problems solved by technology

In view of the complex interaction of various active ingredients of various Chinese medicinal materials in the body, changes in the pharmacokinetics and pharmacodynamics of various drugs in the body will have various effects on the interaction between drugs. When used in combination, it may not only produce synergistic drug effects, but also may produce antagonistic effects, which will lead to weakening of drug therapeutic effect or treatment failure. Some drugs in combination will also increase drug toxicity and cause adverse reactions; Enhanced, but when the therapeutic effect is excessively enhanced, it will exceed the body's ability to tolerate it, and it can also cause adverse reactions and even endanger patients.

Part of the research is to prepare traditional Chinese medicine prescriptions in order to treat ankylosing spondylitis. The most common problem is that the compatibility of the prescriptions is unreasonable, and it is often only based on the individual functions and indications of certain single or compound medicines and certain pharmacodynamic indicators. According to the theory of traditional Chinese medicine, the taste of prescriptions can be added or subtracted at will, resulting in unreasonable prescriptions, which contradicts the theory of traditional Chinese medicine.